Skip to main content

Jeff Lagasse

By Jeff Lagasse | 11:10 am | July 08, 2024
The court will now consider whether the FTC has the authority to enforce the ban, which was set to take effect September 4.
By Jeff Lagasse | 10:28 am | July 05, 2024
Gross margins per enrollee ranged from $753 in the Medicaid managed care market to $1,982 in the MA market.
By Jeff Lagasse | 03:02 pm | July 03, 2024
Infants and toddlers can be challenging to evaluate partly because of their limited ability to communicate symptoms, authors say.
By Jeff Lagasse | 11:06 am | July 03, 2024
The move was announced after Oregon regulators said they were investigating the merger for potential anticompetitive effects.
By Jeff Lagasse | 08:17 pm | July 02, 2024
TeamBirth is a shared decision-making model that focuses on improving communication to bolster quality.
By Jeff Lagasse | 10:51 am | June 21, 2024
While consumers are often enticed by convenience, trust is what retains them, the survey shows.
By Jeff Lagasse | 03:33 pm | June 20, 2024
The agreement was spurred by an investigation into potential violations of patient rights in the State of Iowa.
By Jeff Lagasse | 10:37 am | June 20, 2024
PA is also leading to unnecessary spending and unnecessary hospital stays, according to the AMA survey.
By Jeff Lagasse | 04:28 pm | June 19, 2024
The agency does not anticipate that a change to KP.2 will delay the availability of the vaccines in the U.S.
By Jeff Lagasse | 09:41 am | June 19, 2024
A Medicare beneficiary who takes at least one medication available through RxPass could save approximately $70 per year, retailer says.